Aditum Bio

Light shining through a hatching egg

Biotech

VC firm, Chinese biotech launch autoimmune-focused Oblenio Bio

Oblenio was spun out of Leads Biolabs, which can receive up to $35 million in upfront and near-term payments and $579 million in milestone payments.

Darren Incorvaia Nov 7, 2024 11:35am

Joe Jimenez

Aditum finds twist on old idea, paying $10M for BTK inhibitor

Apr 28, 2023 6:11am

Parachute

Before exiting J&J, Gorsky lands on Apple board—Chutes & Ladders

Nov 12, 2021 9:30am

Parachute

Joe Jimenez's Ancora Bio poaches Sage CMO to revive Taisho drug

Nov 8, 2021 10:50am

Aditum launches Ancora with rights to Taisho's depression drug

Jul 1, 2021 11:51am

Novartis alums Jimenez, Fishman unveil their next act

Nov 2, 2020 7:00am